Hacker News new | ask | show | jobs
by f6v 184 days ago
Yes, we were doing a clinical trial where the primary tumor was irradiated which causes antigen release. The patients were given immune checkpoint inhibitors at the same time to activate immune cells. It's promising but tricky.